H. Nordin

发表

University of Southern Denmark Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry Ibfelt, Else

Ada, Colic, J. Sørensen, 2017 .

Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry

A. Loft, M. Østergaard, U. Tarp, 2012, Annals of the rheumatic diseases.

FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

B. Glintborg, M. Hetland, S. Chrysidis, 2017 .

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

A. Loft, I. Hansen, B. Glintborg, 2017, Annals of the rheumatic diseases.

Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor α inhibitor therapy: results from the Danish Nationwide DANBIO Registry.

A. Loft, M. Ostergaard, U. Tarp, 2013, Arthritis and rheumatism.

Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.

A. Loft, B. Gudbjornsson, B. Glintborg, 2014, Rheumatology.

Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry

A. Loft, L. Dreyer, L. Mellemkjær, 2012, Annals of the rheumatic diseases.

Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry

A. Loft, J. Sørensen, L. Dreyer, 2017, Clinical epidemiology.

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

A. Loft, I. Hansen, F. Mehnert, 2018, Annals of the rheumatic diseases.

Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry.

L. Dreyer, B. Glintborg, G. Kollerup, 2016, Rheumatology.

Discordance of Global Assessments by Patient and Physician Is Higher in Female than in Male Patients Regardless of the Physician’s Sex: Data on Patients with Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis from the DANBIO Registry

T. Pincus, T. Ellingsen, L. Dreyer, 2015, The Journal of Rheumatology.

Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry

A. Loft, M. Østergaard, J. K. Pedersen, 2017, The Journal of Rheumatology.

OP0235-HPR Targeted Information on Methotrexate and Lifting Alcohol Restrictions in Patients with RA and PSA is Safe and Reduces Patients’ Negative Beliefs

J. Larsen, H. Nordin, 2013 .

One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept: – an Observational Study from the Danish Danbio Registry

A. Loft, I. Hansen, B. Glintborg, 2017 .

Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry

A. Loft, L. Dreyer, L. Mellemkjær, 2012, Annals of the rheumatic diseases.

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

A. Loft, I. Hansen, B. Glintborg, 2017, Annals of the rheumatic diseases.

SAT0371 Hla-B27 Status Is Associated with tnfα Inhibitor Treatment Outcomes in Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis – Observational Cohort Study from The Nationwide Danbio Registry

M. Østergaard, J. K. Pedersen, L. Dreyer, 2016 .